Glioblastoma: open trials in Sweden

• NCT06914128

  A Study of PRMT5 Inhibitor BAY 3713372 in Participants With MTAP-deleted Solid Tumors

  Trial Treatment · Phase 1/2 · Bayer

  Sahlgrenska Universitetssjukhuset - Sahlgrenska Sjukhuset - Klinisk prövningsenhet Fas I/FIH, Gothenburg · Karolinska Universitetssjukhuset - Solna - Fas I-enheten Solna CKC, Stockholm

  Registry updated 2026-10-28

• 2023-506998-35-00

  Phase III trial of lomustine/temozolomide (TMZ) combination therapy vs. standard TMZ therapy for newly diagnosed MGMT promoter methylated glioblastoma (IDHwt) patients +/- tumor treating fields (Optune)

  Trial Treatment · Phase 3 · Vaestra Goetalandsregionen

  Malarsjukhuset Eskilstuna, Eskilstuna · Region Dalarna, Falun · Region Gaevleborg, Gavle · Sahlgrenska University Hospital-Vastra Gotalandsregionen, Goteborg · Region Joenkoepings Laen, Jonkoping · Laenssjukhuset I Kalmar Region Kalmar Laen, Kalmar · Region Vaermland, Karlstad · Region Oestergoetland, Linkoping · Region Skane Skanes Universitetssjukhus, Lund · Region Oerebro Laen, Orebro · Karolinska University Hospital, Solna · Region Vaesternorrland, Sundsvall · Region Vaesterbotten, Umea · Uppsala University Hospital, Uppsala · Region Vaestmanland, Vasteras

  Registry updated 2026-08-27

• NCT06419946

  Lomustine in Addition to Standard of Care in Patients With MGMT Methylated Glioblastoma

  Trial Treatment · Phase 3 · Vastra Gotaland Region

  Gävle Hospital, Gävle · Sahlgrenska University Hospital, Gothenburg · Ryhov County Hospital, Jönköping · Kalmar Country Hospital, Kalmar · Skåne University Hospital, Lund · Örebro University Hospital, Örebro · Karolinska Institutet, Stockholm · Sundsvall Hospital, Sundsvall · Norrlands Universitetssjukhus, Umea, Sweden, Umeå · Uppsala University Hospital, Uppsala

  Registry updated 2026-04-13

• NCT02394626

  Surgery for Recurrent Glioblastoma

  Trial Treatment · Phase 2 · Insel Gruppe AG, University Hospital Bern

  University of Gothenburg, Department of Clinical Neuroscience, Gothenburg · University Hospital of Umeå, Department of Diagnostics and Intervention, Umeå

  Registry updated 2026-02-02

• NCT07364786

  Effect of Salovum® on Pressure, Oxygen and Inflammation in Glioblastoma

  Trial Treatment · Phase 2 · Peter Siesjö

  Department of Neurosurgery, Skane University Hospital, Lund

  Registry updated 2026-01-23

• NCT05669820

  Antisecretory Factor Glioblastoma Phase 2

  Trial Treatment · Phase 2/3 · Peter Siesjö

  Skåne University Hospital, Lund

  Registry updated 2026-01-09

• NCT06710249

  Impact of Salovum® and SPC® Flakes on Brain Tumor Induced Edema

  Trial Treatment · Phase 2 · Peter Siesjö

  Department of Neurosurgery, Lund

  Registry updated 2025-01-27

All Glioblastoma trials and the map

This page is not medical advice. Talk to your doctor before contacting a trial.

Report an error